Display Settings:

Format

Send to:

Choose Destination
Tidsskr Nor Laegeforen. 2012 Nov 12;132(21):2396-9. doi: 10.4045/tidsskr.12.0120.

Neuroprotective treatment for perinatal asphyxia.

[Article in English, Norwegian]

Author information

  • 1Department of Child and Adolescent Medicine, Akershus University Hospital, Norway. a.l.solevag@medisin.uio.no

Abstract

BACKGROUND:

Perinatal asphyxia can cause serious illness or death. By taking steps in the «latent phase», which occurs 6-24 hours after the hypoxic event, the neurological damage caused by perinatal asphyxia can be limited. We wish to present a selection of such measures that are either established treatment today or that appear promising.

METHOD:

We searched in the Medline and Cochrane Library databases for options for treating perinatal asphyxia.

RESULTS:

An overwhelming number of potential treatments were identified. From among them we selected 44 indexed, peer-reviewed original articles in English on strategies for neuroprotective treatment after perinatal asphyxia. The treatments target different cellular mechanisms that cause neurological damage following perinatal asphyxia. In randomised clinical trials, only hypothermia treatment has improved the long-term outcome for newborns with perinatal asphyxia. Xenon gas, erythropoeitin and allopurinol are undergoing clinical testing.

INTERPRETATION:

The efficacy of xenon gas, erythropoeitin and allopurinol in combination with the established treatment form of hypothermia must be studied more closely. Antioxidants, stem cell treatment and DNA repair mechanisms can pave the way for new opportunities in the future.

PMID:
23160590
[PubMed - indexed for MEDLINE]
Free full text
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Icon for Norwegian Medical Association
    Loading ...
    Write to the Help Desk